Trump signs order to hasten review of psychedelics
Summary
President Donald Trump signed an order to speed up the review of certain psychedelic drugs, such as ibogaine, to explore their use for medical treatments. These drugs are currently banned as high-risk substances, but the administration aims to make research and access easier for conditions like severe depression.Key Facts
- President Trump signed an executive order to accelerate reviews of some psychedelic drugs.
- Ibogaine, a psychedelic, has gained attention from combat veterans and some lawmakers.
- These psychedelics are currently banned under the strictest federal drug category.
- The order aims to ease rules to promote research into medical uses of these drugs.
- Potential treatments could help people with serious symptoms like severe depression.
- President Trump said the move could "dramatically accelerate" access to these treatments.
- The administration hopes this will improve the lives of people with difficult health conditions.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
